Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4469556

CCCCCCCCC(CCCCCCCCCN1C(=O)C=CC1=O)C(CCCCCCCC)CCCCCCCCCN1C(=O)C=CC1=O.N.N

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 8/20 0.76
PTGS1 P23219 7/20 0.76
PTGS2 P35354 7/20 0.76
FAAH O00519 5/20 0.76
ALDH1A1 P00352 3/20 0.59
LMNA P02545 2/20 0.59
MAPT P10636 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
HSP90AA1 P07900 1/20 0.59
TLR9 Q9NR96 1/20 0.59
TP53 P04637 1/20 0.59
PKM P14618 1/20 0.59
HPGD P15428 1/20 0.59
XBP1 P17861 1/20 0.59
MAPK1 P28482 1/20 0.59
HTT P42858 1/20 0.59
RECQL P46063 1/20 0.59
RAB9A P51151 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
GPR35 Q9HC97 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL634042 0.98 MGLL (0.79) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL15854884 0.98 MGLL (0.79) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL15853885 0.98 MGLL (0.79) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL21610374 0.89 MGLL (0.65) MGLLPTGS1PTGS2FAAHALDH1A1
Ammonia Solution, Strong SCHEMBL27903574 0.89 MGLL (0.96) MGLLPTGS1PTGS2FAAHALDH1A1
Ammonia Solution, Strong SCHEMBL27921281 0.89 MGLL (0.96) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL9640374 0.87 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL9497658 0.87 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL209436 0.87 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL2181536 0.87 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517925-B2 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof HENKEL CORPORATION (US) 2009-04-14 US disclosed
US-20040123948-A1 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof LOCTITE CORPORATION 2004-07-01 US disclosed
US-6743852-B2 A THERMOSETTING RESIN COMPOSITION CONTAINING A BENZOXAZINE COMPOUND WITH A POLYMERIZABLE MOITY, AND A CURING AGENT HENKEL CORPORATION 2004-06-01 US disclosed
US-20030125551-A1 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof LOCTITE CORPORATION 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125551-A1 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof TMPO, ALOX5, KDM5A MGLL 4369/4885PTGS1 969/4885PTGS2 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.